技術指標
指標
數值
方向
MACD(12,26,9)
-0.277
賣出
RSI(14)
40.103
中性
STOCH(KDJ)(9,3,3)
13.030
超賣
ATR(14)
0.354
高波動
CCI(14)
-113.744
賣出
Williams %R
93.333
超賣
TRIX(12,20)
-0.231
賣出
StochRSI(14)
0.000
賣出
搜尋
Telix Pharmaceuticals Ltd
TLX添加自選
9.910USD
-0.150-1.49%
收盤 07-31 16:00（美東）報價延遲15分鐘
0.00總市值
--本益比TTM
關鍵數據
10.000今開
10.012最高
80.93K成交量
--本益比TTM
0.00本益比動
--股利TTM
--換手率
10.060昨收
9.790最低
612.50K成交額
--本益比靜
--市淨率
0.00%股息率 TTM
--ROA
18.49052週最高
1.02量比
--淨利潤
--總股本
--每股盈餘TTM
--Beta
--ROE
6.28052週最低
2.21%振幅
--毛利率
0.00總市值
-8.69回報/風險
1.75%風險率
Telix Pharmaceuticals Ltd新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
5
分析師
強力買入
評級
19.291
目標均價
+91.00%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
496
總數
6
中位數
7
平均值
公司名稱
評級分佈
分析師數
Telix Pharmaceuticals Ltd
TLX
5
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
技術指標
移動平均線
指標
數值
方向
MA5
10.044
賣出
MA10
10.270
賣出
MA20
10.781
賣出
MA50
10.310
賣出
MA100
10.074
賣出
MA200
9.305
買入
Telix Pharmaceuticals Ltd簡介
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
公司代碼TLX
公司Telix Pharmaceuticals Ltd
CEOOrtiz (Raphaeel)
網址https://telixpharma.com/
公司股東
熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
Telix Pharmaceuticals Ltd(TLX)的當前股價是多少？
Telix Pharmaceuticals Ltd(TLX)的當前股價是 9.91。
Telix Pharmaceuticals Ltd 的股票代碼是什麼？
Telix Pharmaceuticals Ltd的股票代碼是TLX。
Telix Pharmaceuticals Ltd股票的52週最高點是多少？
Telix Pharmaceuticals Ltd股票的52週最高點是18.49。
Telix Pharmaceuticals Ltd股票的52週最低點是多少？
Telix Pharmaceuticals Ltd股票的52週最低點是6.28。
現在Telix Pharmaceuticals Ltd(TLX)的股票是買入、持有還是賣出？
根據分析師評級，Telix Pharmaceuticals Ltd(TLX)的總體評級為STRONG BUY，目標價格為19.29。